AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 1 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $349,000 | -12.3% | 147,800 | 0.0% | 0.00% | -20.0% |
Q1 2019 | $398,000 | +50.8% | 147,800 | +64.2% | 0.01% | +66.7% |
Q3 2018 | $264,000 | +98.5% | 90,000 | +80.0% | 0.00% | +200.0% |
Q2 2018 | $133,000 | -81.1% | 50,000 | 0.0% | 0.00% | -87.5% |
Q1 2018 | $704,000 | +19.7% | 50,000 | 0.0% | 0.01% | +33.3% |
Q4 2017 | $588,000 | -17.2% | 50,000 | 0.0% | 0.01% | -25.0% |
Q3 2017 | $710,000 | +0.9% | 50,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $704,000 | -15.7% | 50,000 | 0.0% | 0.01% | -20.0% |
Q1 2017 | $835,000 | +1.1% | 50,000 | 0.0% | 0.01% | -9.1% |
Q4 2016 | $826,000 | -0.2% | 50,000 | -19.4% | 0.01% | -8.3% |
Q3 2016 | $828,000 | +102.0% | 62,000 | 0.0% | 0.01% | +100.0% |
Q2 2016 | $410,000 | +286.8% | 62,000 | +416.7% | 0.01% | +200.0% |
Q1 2016 | $106,000 | -43.3% | 12,000 | -20.0% | 0.00% | -33.3% |
Q4 2015 | $187,000 | -11.4% | 15,000 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $211,000 | +102.9% | 15,000 | 0.0% | 0.00% | +100.0% |
Q2 2015 | $104,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |